Achilles Pain Block

Summary

Achilles Pain Block is a clinical trial^[1].

Key Facts

• Achilles Pain Block is in the country of United States^[2].
• Achilles Pain Block's instance of is recorded as clinical trial^[3].
• Achilles Pain Block's start time is recorded as +2016-01-28T00:00:00Z^[4].
• Achilles Pain Block's end time is recorded as +2018-05-10T00:00:00Z^[5].
• Achilles Pain Block's main subject is recorded as pain^[6].
• Achilles Pain Block's number of participants is recorded as {'unit': '1', 'amount': '+46'}^[7].
• Achilles Pain Block's title is recorded as Impact of Peripheral Pain Perception on Central Sensitization and Movement Strategies in Patients With Chronic Achilles Tendinopathy^[8].
• Achilles Pain Block's short name is recorded as APB^[9].
• Achilles Pain Block's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Achilles Pain Block's ClinicalTrials.gov ID is recorded as NCT03316378^[11].
• Achilles Pain Block's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[12].
• Achilles Pain Block's research intervention is recorded as (S)-ropivacaine^[13].
• Achilles Pain Block's clinical trial phase is recorded as phase II clinical trial^[14].
• Achilles Pain Block's clinical trial phase is recorded as phase III clinical trial^[15].
• Achilles Pain Block's research site is recorded as University of Iowa Health Care^[16].
• Achilles Pain Block's study type is recorded as interventional study^[17].